<a href=

Regional website


target="_blank" style="text-decoration: underline">

Regional website


Cataluña (ES51)

The North-Eastern region of Cataluña is one of Spain’s most prosperous. It has population of 7.3 million. With strong government backing, the region is now focused on developing its capabilities in personalised medicine and the use of big data.


The Catalan government’s Research and Innovation in Health Directorate have stated that personalised medicine is a key priority for the region. The science and infrastructure are already available, the goal is to move to make personalised healthcare an area of interest and build on the available assets that exist within the region.

Fundació TicSalut Social

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes

Policy documents


  1. National  Recommendations proposal for a state strategy http://www.aegh.org/wp-content/uploads/2017/04/Propuesta-de-Recomendaciones-MPP-_-Def.pdf 

  2. National  A status report about personalized medicine in Spain  https://www.institutoroche.es/static/pdfs/MPP_EN_ESPANA_MAPA_DE_CCAA.pdf 

Major initiatives


  1. GCAT- Genomics for lyfe  http://www.gcatbiobank.org/qui-som/en_index/Barcelona

  2. Supercomputing Centre - Marenostrum  Super computer, Genomics, molecular modeling, https://www.bsc.es/research-and-development/research-development

  3. CRG- Centre for genomic regulation  international biomedical research institute, genomics, bioinformatics, proteomics, tissue engineering  https://www.crg.eu/en/content/about-us/general-information

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?


  1. CeLac and European consortium for a personalized medicine approach to Gastric Cancer

  2. IndividualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology

  3. EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine

  4. SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine

  5. ERA-Net Cofund in Personalised Medicine


This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium